Methods and pharmaceutical compositions for modulating autophagy in a subject in need thereof

a technology of autophagy and pharmaceutical compositions, applied in drug compositions, metabolic disorders, cardiovascular disorders, etc., can solve problems such as maladaptive tissue remodeling

Inactive Publication Date: 2016-09-01
INST NAT DE LA SANTE & DE LA RECHERCHE MEDICALE (INSERM) +6
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although autophagy plays a major role in antagonizing degenerative processes and unwarranted cell death, its excessive inductio

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods and pharmaceutical compositions for modulating autophagy in a subject in need thereof
  • Methods and pharmaceutical compositions for modulating autophagy in a subject in need thereof
  • Methods and pharmaceutical compositions for modulating autophagy in a subject in need thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

Chemicals, Cell Lines and Culture Conditions

[0110]Unless otherwise specified, chemicals were purchased from Sigma-Aldrich (St. Louis, USA), culture media and supplements for cell culture from Gibco-Invitrogen (Carlsbad, USA) and plastic ware from Corning (Corning, USA). Human colon carcinoma HCT 116 cells were cultured in McCoy's 5A medium containing 10% fetal bovine serum, 100 mg / L sodium pyruvate, 10 mM HEPES buffer, 100 units / mL penicillin G sodium and 100 μg / mL streptomycin sulfate (37° C., 5% CO2). Human osteosarcoma U2Os cells, their GFP-LC3-expressing derivatives, human neuroblastoma H4 GFP-LC3 (gift from Prof J. Yuan) cells and human GFP-LC3-expressing HeLa cells were cultured in DMEM medium containing 10% fetal bovine serum, 100 mg / L sodium pyruvate, 10 mM HEPES buffer, 100 units / mL penicillin G sodium and 100 μg / mL streptomycin sulfate (37° C., 5% CO2). Mouse embryo fibroblasts (MEFs) were cultured in the same DMEM with additional supplementation of non-essential amino-aci...

example 2

Results

[0154]Inhibition of Autophagy by Acetyltransferases and Acetylproteins.

[0155]One of the best-studied physiological inducers of autophagy is energy depletion, as it results from exposing cells to nutrient-free media or by subjecting mice to starvation (Mizushima and Komatsu, 2011). Mass spectrometric metabolomic profiling of starved cells (in vitro) or organs (in vivo) revealed the intracellular depletion of very few common metabolites including acetyl CoA (AcCoA). Starvation-induced AcCoA depletion could be confirmed in murine and human cell lines, both in total cellular homogenates and cytosolic fractions, with a stronger effect observed in the latter. Interestingly, the starvation-induced decrease of AcCoA was not accompanied by the depletion of neither ATP nor NADH at the analyzed incubation times. In mice, heart and muscle tissues respond to nutrient depletion by mounting a strong autophagic response (Mizushima et al., 2004), which we found to be commensurated with a dras...

example 3

Results

[0180]Starvation Induces Depletion of Acetyl-CoA and Protein Deacetylation

[0181]Autophagy can be potently induced by exposing cells to nutrient-free media or by subjecting mice to starvation (Mizushima and Komatsu, 2011). Mass spectrometric metabolomic profiling of starved cells (in vitro) or organs (in vivo) revealed the intracellular depletion of very few common metabolites, one of which was AcCoA. Starvation-induced AcCoA depletion could be confirmed in murine and human cell lines, both in total cellular homogenates and in cytosolic fractions. At the analyzed short (<6 hr) incubation times, the starvation-induced decrease of AcCoA was not accompanied by the depletion of ATP or NADH. In mice, heart and muscle tissues responded to nutrient depletion by mounting a strong autophagic response (Mizushima et al., 2004), which we found to be commensurate with a reduction in AcCoA levels and a decrease in cytoplasmic protein acetylation. In contrast, brain tissue, in which autophag...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Timeaaaaaaaaaa
Timeaaaaaaaaaa
Timeaaaaaaaaaa
Login to view more

Abstract

The present invention provides novel methods for the modulation of autophagy and the treatment of autophagy-related diseases, including cancer, neurodegenerative diseases, liver diseases, muscle diseases and pancreatitis.

Description

FIELD OF THE INVENTION[0001]The present inventions relates to methods and pharmaceutical compositions for modulating (i.e. inducing or inhibiting) autophagy in a subject in need thereof.BACKGROUND OF THE INVENTION[0002]Macroautophagy (“autophagy”) involves the highly regulated sequestration of cytoplasmic organelles or portions of the cytosol in double-membrane vesicles, called autophagosomes, which fuse with lysosomes resulting in the degradation of the inner autophagosomal membrane and luminal content (Mizushima and Komatsu, 2011). Autophagy plays an essential role in cellular adaptation to multiple types of stress, recycling of superfluous or damaged cellular material, quality control of organelles, removal of protein aggregates, and destruction of intracellular pathogens (Kroemer et al., 2010). Disabled or insufficient autophagy participates in the pathogenesis of multiple infectious diseases, autoimmune or autoinflammatory states, malignant transformation, neuro- or myodegenera...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/7076A61K31/4458A61K31/235A61K45/06A61K31/4155A61K31/22A61K31/385A61K31/19A61K31/405A61K31/225
CPCA61K31/7076A61K31/405A61K31/4458A61K31/235A61K45/06A61K31/4155A61K31/22A61K31/385A61K31/19A61K31/225A61K31/194A61K31/216A61K31/7008A61P3/00A61P9/00A61P25/00A61P29/00A61P31/00A61P35/00
Inventor KROEMER, GUIDOMARINO, GUILLERMOPIETROCOLA, FEDERICO
Owner INST NAT DE LA SANTE & DE LA RECHERCHE MEDICALE (INSERM)
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products